Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Eugenio Greco,
Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative A. L. Culver et al. Arch Intern Med 2012; Advance online publication
Statin use in postmenopausal women is associated with an increased risk of developing Diabetes Mellitus, probably due to a medication class effect: this is the conclusion of Culver et al, in a study published in the Arch Inter Med, on a large cohort of women enrolled in the Women's Health Initiative. This investigation included 153 840 women without Diabetes Mellitus. Statin use at baseline was associated with an increased risk of Diabetes Mellitus (hazard ratio, 1.71; 95% CI, 1.61-1.83), moreover this association was observed for all types of statin medications. These data confirm and extend associations demonstrated in other previous studies, giving new insights in the risk-benefit analysis of statin use as primary prevention.